WHO WE ARE

DELIVERING
THE PROMISE
OF TARGETED
GENE THERAPY

NanoGenics is the leading company developing the artificial virus, a new kind of vector for gene therapy.

We have committed to overcoming the obstacle of delivery to fulfil the promise of gene therapy, working alongside innovative partners to bring cutting-edge treatments to market.

Read more about who we are...

WHAT WE DO

Introducing LipTide: The artificial virus

LipTide is a revolutionary nanoscale delivery vehicle invented to mimic a natural virus for targeted delivery of all forms DNA and RNA into cells.

With appealing clinical properties and the capability to deliver genetic material to almost any cell type, LipTide can help realise the potential of your gene therapy.

Read more about what we do...

Image

Working with you

Every component of LipTide can be customised for purpose, offering unprecedented flexibility in target and payload.

Together, we can develop a bespoke research plan and create a LipTide solution to get your gene therapy from pipeline to patient.
Read more about working with you...

Image

OUR PIPELINE

We have an ongoing programme to bring LipTide to the clinic. Several promising gene
therapy treatments using LipTide are already in development in-house at NanoGenics.
Image

A chemotherapy
enhancer

Image

An inhaled treatment 
for cystic fibrosis

Image

A neuroblastoma
tumour growth suppressor

Image

A novel glaucoma
therapy

Your Team

Meet our multidisciplinary team of experts committed to realising the possibilities of gene therapy.

Read more about your team...
Image

INVESTING IN US

LipTide offers a vision of the future of gene therapy. We are exploring partnership opportunities to accelerate our exciting programmes. To find out more, please contact:
alan.walker@nanogenics.co.uk

Image

Latest News

Image